Novartis (NYSE: NVS) reported Q2 EPS of $1.34, $0.12 better than the analyst estimate of $1.22. Revenue for the quarter ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE